Home - Products - Others - Other Targets - Apigenin 5-O-beta-D-glucopyranoside

Apigenin 5-O-beta-D-glucopyranoside

CAS No. 28757-27-9

Apigenin 5-O-beta-D-glucopyranoside( —— )

Catalog No. M30915 CAS No. 28757-27-9

Apigenin 5-O-beta-D-glucopyranoside has inhibitory activity against the enzyme yeast a-glucosidase, withthe IC50 value of 287.12 muM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 360 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Apigenin 5-O-beta-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Apigenin 5-O-beta-D-glucopyranoside has inhibitory activity against the enzyme yeast a-glucosidase, withthe IC50 value of 287.12 muM.
  • Description
    Apigenin 5-O-beta-D-glucopyranoside has inhibitory activity against the enzyme yeast a-glucosidase, withthe IC50 value of 287.12 muM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    28757-27-9
  • Formula Weight
    432.4
  • Molecular Formula
    C21H20O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ADA

    ADA is a biological buffer which can serve as a chelator.

  • Eledoisin trifluoroa...

    Eledoisin is a peptide extracted from the posterior salivary glands of certain small octopi (Eledone spp., Mollusca), or obtained by synthesis.?Its actions resemble those of SUBSTANCE P;?it is a potent vasodilator and increases capillary permeability.

  • Norisoboldine

    Norisoboldine might be a potential therapeutic agent for rheumatoid arthritis, and it functions through protecting joint destruction as well as regulating the abnormal immune responses.